Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WEED, Inc. is a multi-national holding company focused on the development and application of cannabis-derived compounds for the pharmaceutical and agricultural markets. Through its subsidiary, Sangre AgroTech, the company utilizes advanced genomic research and molecular biology to identify and isolate specific cannabis strains for medicinal use. Their primary objective is to establish a global supply chain for standardized, pharmaceutical-grade cannabis products targeting various human and animal diseases. The company operates at the intersection of biotechnology and the legal cannabis industry, emphasizing scientific validation and genomic mapping. WEED, Inc. aims to provide a bridge between traditional medicine and the therapeutic potential of the cannabis plant through rigorous scientific study.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weed Holdings.